Organization

Meir Medical Center

7 clinical trials

4 abstracts

Abstract
Exploratory biomarker analysis of the phase 3 KEYNOTE-604 study of pembrolizumab plus etoposide for extensive-stage SCLC.
Org: Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea, Memorial Sloan Kettering Cancer Center, Vall d’Hebron University Hospital/VHIO, Lausanne University Hospital, William Osler Health System,
Clinical trial
Epidural vs. Systemic Analgesia in the Intensive Care Unit: Retrospective Study
Status: Completed, Estimated PCD: 2023-04-01
Clinical trial
Vitamin C Administration and Triglycerides Level in Critical Care Patients: a Retrospective Study
Status: Not yet recruiting, Estimated PCD: 2027-02-01
Abstract
Treatments and clinical outcomes in stage II colon cancer (CC) patients (pts) with 12-gene Oncotype DX Colon Recurrence Score assay-guided therapy: Real-world data.
Org: Rabin Medical Center Davidoff Cancer Centre, Lin Medical Center, Hadassah-Hebrew University Medical Center, Soroka University Medical Center, Tel Aviv Sourasky Medical Center,
Abstract
αVβ3 INTEGRIN AS A LINKER BETWEEN FIBROSIS AND THYROID HORMONES CROSSTALK
Org: Tel-Aviv University Medical School, Sackler Faculty of Medicine, Meir Medical Center, Autoimmune Laboratory, Data Research Department,
Abstract
ASSESSLE- A NEW TOOL TO ASSESS SLE DISEASE ACTIVITY- THE PATIENTS’ PERSPECTIVE
Org: Tel-Aviv Medical Center, Rheumatology, Tel Aviv, Israel, Tel-Aviv University Medical School, Meir Medical Center, Sheba Medical Center, Or-Yeuda,